CBLL (CBLL)
Market: NASD |
Currency: USD
Address: 360 North Pastoria Avenue
CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.
📈 CBLL Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$31.00
-
Upside/Downside from Analyst Target:
74.16%
-
Broker Call:
12
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
25-50%
-
Revenue Growth Range (1Y):
25-50%
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for CBLL
Date | Reported EPS |
---|
2025-02-25 | -0.4 |
2024-11-12 | -1.85 |
2024-11-07 | - |
2024-10-11 | - |
📰 Related News & Research
No related articles found for "cbll".